Los Angeles Capital Management LLC Acquires 20,022 Shares of DaVita Inc. (NYSE:DVA)

Los Angeles Capital Management LLC lifted its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 800.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,523 shares of the company's stock after acquiring an additional 20,022 shares during the period. Los Angeles Capital Management LLC's holdings in DaVita were worth $3,692,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Transcendent Capital Group LLC purchased a new position in shares of DaVita during the 3rd quarter valued at about $25,000. Blue Trust Inc. grew its stake in shares of DaVita by 58.6% during the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company's stock worth $29,000 after purchasing an additional 78 shares during the period. Family Firm Inc. purchased a new stake in shares of DaVita in the second quarter valued at $43,000. Versant Capital Management Inc lifted its position in DaVita by 90.6% during the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company's stock worth $45,000 after acquiring an additional 155 shares in the last quarter. Finally, Friedenthal Financial acquired a new position in shares of DaVita in the 2nd quarter valued at about $48,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on DVA. TD Cowen increased their price objective on DaVita from $139.00 to $150.00 and gave the stock a "hold" rating in a report on Wednesday, July 24th. Barclays lifted their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research report on Thursday, October 31st. UBS Group upped their target price on DaVita from $169.00 to $175.00 and gave the company a "buy" rating in a research report on Thursday, August 8th. Truist Financial lifted their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Finally, Bank of America boosted their target price on DaVita from $139.00 to $145.00 and gave the company an "underperform" rating in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $161.80.

DaVita Stock Performance

NYSE DVA traded down $0.81 on Wednesday, hitting $157.23. The stock had a trading volume of 794,807 shares, compared to its average volume of 819,573. The stock has a market cap of $12.89 billion, a price-to-earnings ratio of 17.02, a P/E/G ratio of 0.89 and a beta of 0.89. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. DaVita Inc. has a one year low of $89.33 and a one year high of $168.50. The company's 50-day moving average is $157.34 and its two-hundred day moving average is $147.23.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the company earned $2.85 EPS. The firm's revenue was up 4.6% compared to the same quarter last year. On average, analysts expect that DaVita Inc. will post 9.71 earnings per share for the current year.

Insider Transactions at DaVita

In other news, CEO Javier Rodriguez sold 32,176 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the transaction, the chief executive officer now owns 905,659 shares in the company, valued at approximately $141,219,407.87. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, COO Michael David Staffieri sold 9,539 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares of the company's stock, valued at approximately $36,299,008.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the transaction, the chief executive officer now directly owns 905,659 shares in the company, valued at $141,219,407.87. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 165,625 shares of company stock worth $26,238,297 over the last ninety days. 2.00% of the stock is owned by insiders.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.